verified
SJR 0,286 · Q2
•
database
Scopus / SJR & Web of Science indexed
United Kingdom · Taylor and Francis Ltd.
workspace_premium
Q2 — Health Policy
lock
Subscription
Expert Opinion on Orphan Drugs
Expert Opinion on Orphan Drugs is a journal indexed in SJR in Health Policy and Pharmacology (medical) with an H index of 29. It has a price of 1800 €. It has an SJR impact factor of 0,286 and it has a best quartile of Q2. It has an SJR impact factor of 0,286.
Publisher: Taylor and Francis Ltd.
Category: Health Policy
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,286
Q2
H-index
29
Acceptance rate
pie_chart
39%
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
1.800 €
Subscription
Non-OA path
0 €
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
0,286
H-index
29
Docs (year)
5
Docs 3y
39
Total refs
349
Cites 3y
34
Citable 3y
36
Cites/Doc 2y
1.09
Ref/Doc
69.8
Immediate OA
1800 €
Embargoed OA
NPD
Non OA / Submission
0 €
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.